Literature DB >> 16969073

PV-1 is negatively regulated by VEGF in the lung of caveolin-1, but not caveolin-2, null mice.

Robert Hnasko1, Philippe G Frank, Nira Ben-Jonathan, Michael P Lisanti.   

Abstract

An N-glycosylated 60-kDa PV-1 protein that binds heparin was detected in mouse lung from a single mRNA transcript. In the absence of disulfide bond reduction PV-1 is detected as a dimer or large molecular weight oligomer. In the lung of Cav-1, but not Cav-2, null mice the amount of PV-1 protein is diminished, with no detectable change in mRNA level. PV-1 does not fractionate with caveolae on a sucrose density gradient, but the Cav-1 protein is detected in fractions following immunoprecipitation with PV-1 antibodies. Both PV-1 and Cav-1 localize to alveolar endothelial cells, but PV-1 is concentrated at the abluminal and Cav-1 at the luminal cell surface with minimal colocalization. In the Cav-1 null lungs, PV-1 is nearly undetectable in endothelial cells, but remains unchanged in pneumocytes and bronchial epithelial cells. Injection of a VEGF-R2 inhibitor increased PV-1 protein in lung of Cav-1 null, but not Cav-2 or wild-type mice. These data indicate that the PV-1 protein is negatively regulated in pulmonary endothelial cells by VEGF-R2 signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969073     DOI: 10.4161/cc.5.17.3216

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  8 in total

1.  Anti-IL-6 neutralizing antibody modulates blood-brain barrier function in the ovine fetus.

Authors:  Jiyong Zhang; Grazyna B Sadowska; Xiaodi Chen; Seon Yeong Park; Jeong-Eun Kim; Courtney A Bodge; Erin Cummings; Yow-Pin Lim; Oleksandr Makeyev; Walter G Besio; John Gaitanis; William A Banks; Barbara S Stonestreet
Journal:  FASEB J       Date:  2015-01-21       Impact factor: 5.191

2.  The diaphragms of fenestrated endothelia: gatekeepers of vascular permeability and blood composition.

Authors:  Radu V Stan; Dan Tse; Sophie J Deharvengt; Nicole C Smits; Yan Xu; Marcus R Luciano; Caitlin L McGarry; Maarten Buitendijk; Krishnamurthy V Nemani; Raul Elgueta; Takashi Kobayashi; Samantha L Shipman; Karen L Moodie; Charles P Daghlian; Patricia A Ernst; Hong-Kee Lee; Arief A Suriawinata; Alan R Schned; Daniel S Longnecker; Steven N Fiering; Randolph J Noelle; Barjor Gimi; Nicholas W Shworak; Catherine Carrière
Journal:  Dev Cell       Date:  2012-12-11       Impact factor: 12.270

3.  Caveolae, fenestrae and transendothelial channels retain PV1 on the surface of endothelial cells.

Authors:  Eugene Tkachenko; Dan Tse; Olga Sideleva; Sophie J Deharvengt; Marcus R Luciano; Yan Xu; Caitlin L McGarry; John Chidlow; Paul F Pilch; William C Sessa; Derek K Toomre; Radu V Stan
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

4.  Plasmalemma vesicle-associated protein: A crucial component of vascular homeostasis.

Authors:  Ling Guo; Hongyan Zhang; Yinglong Hou; Tianshu Wei; Ju Liu
Journal:  Exp Ther Med       Date:  2016-07-27       Impact factor: 2.447

Review 5.  The role of plasmalemma vesicle-associated protein in pathological breakdown of blood-brain and blood-retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema.

Authors:  Esmeralda K Bosma; Cornelis J F van Noorden; Reinier O Schlingemann; Ingeborg Klaassen
Journal:  Fluids Barriers CNS       Date:  2018-09-20

6.  Phorbol esters induce PLVAP expression via VEGF and additional secreted molecules in MEK1-dependent and p38, JNK and PI3K/Akt-independent manner.

Authors:  B JoNell Hamilton; Dan Tse; Radu V Stan
Journal:  J Cell Mol Med       Date:  2018-11-05       Impact factor: 5.310

Review 7.  Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier.

Authors:  Simon C Satchell; Filip Braet
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-07

Review 8.  Endothelial stomatal and fenestral diaphragms in normal vessels and angiogenesis.

Authors:  R V Stan
Journal:  J Cell Mol Med       Date:  2007 Jul-Aug       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.